Dasotraline Binge Eating Disorder Extension Study
Clinical trial NCT02684279 · COMPLETED
Trial details
- NCT number
- NCT02684279
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2019-06-24
- Enrollment
- 533
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.